Susquehanna Fundamental Investments’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,075
Closed -$306K 1013
2024
Q1
$306K Buy
+8,075
New +$306K 0.01% 551